시장보고서
상품코드
1824464

세계의 척수 자극 시장 보고서(2025년)

Spinal Cord Stimulation Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

척수 자극 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.7%로 성장할 전망이며, 47억 6,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 혁신적인 자극 요법의 개발, 척수 자극의 용도 확대, 저침습 기술 수요 증가, 연구개발 투자 증가, 상환 정책 등에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 척수 자극 기기에 인공지능의 통합, 비마취 기반 자극의 출현, 신흥경제국 시장 존재 확대에 대한 주력, 충전식 자극 기기의 채용, 제품 개발에 있어서 환자 중심 접근의 중시 등을 들 수 있습니다.

향후 5년간의 성장률 8.7%라고 하는 예측은 전회 예측으로부터 0.2%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 마찰은 스위스와 아일랜드에서 개발된 이식 가능한 신경 자극 기기 및 충전식 배터리 시스템의 가격을 올리고 환자의 고통을 늘리며 페인 클리닉 비용을 증가시킴으로써 미국의 고도 통증 관리의 도입을 방해할 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

척수 손상의 유병률 증가가 예상에 따라 척수 자극 시장의 향후 성장이 예상됩니다. 척수 손상은 척추관 내의 척수와 신경에 대한 모든 손상을 포함하며, 종종 외상성 사고 및 가정 사고로 인해 발생합니다. 척수 손상의 치료에는 척수에 저전압 전기를 흘려 통증을 완화시키는 '척수 자극'이 사용됩니다. 2022년 5월 현재 미국 국립의학 도서관의 보고에 따르면 척수 손상은 전 세계적으로 매년 25만 명에서 50만 명에 영향을 미칩니다. 미국만으로도 매년 약 17,000명의 척수 손상이 새롭게 보고되고 있으며, 추정 282,000명의 미국인이 척수 손상의 생존자로 간주되고 있습니다. 그 결과, 척수 손상의 유병률 증가는 척수 자극 시장 확대의 기폭제가 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

  • 세계의 척수 자극 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 척수 자극 시장 : 성장률 분석
  • 세계의 척수 자극 시장 실적 : 규모 및 성장(2019-2024년)
  • 세계의 척수 자극 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
  • 세계의 척수 자극 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 척수 자극 시장 : 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 충전식
  • 비충전식
  • 세계의 척수 자극 시장 : 적응증별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 등 수술 실패 증후군(FBSS)
  • 변성 추간판 질환(DDD)
  • 복합성 국소 통증 증후군(CRPS)
  • 거미막염
  • 기타 질환의 적응증
  • 세계의 척수 자극 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 병원
  • 외래수술센터(ASC)
  • 전문 클리닉
  • 세계의 척수 자극 시장 : 충전식 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 이식형 펄스 발생기(IPG)
  • 충전식 납 시스템
  • 세계의 척수 자극 시장 : 비충전식 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 비충전식 이식형 펄스 발생기(IPG)
  • 비충전식 납 시스템

제7장 지역별 및 국가별 분석

  • 세계의 척수 자극 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 세계의 척수 자극 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

  • 척수 자극 시장 : 경쟁 구도
  • 척수 자극 시장 : 기업 프로파일
    • Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Medtronic PLC : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Stryker Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Boston Scientific Corp. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • LivaNova PLC : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Globus Medical Inc.
  • ZimVie Inc.
  • Avanos Medical Inc.
  • Nevro Corp.
  • Axonics Modulation Technologies Inc.
  • SPR Therapeutics Inc.
  • BlueWind Medical
  • Bioness Inc.
  • Saluda Medical Pty. Ltd.
  • Soterix Medical Inc.
  • Synapse Biomedical Inc.
  • NeuroMetrix Inc.
  • NDI Medical LLC
  • Neuros Medical Inc.
  • Cirtec Medical Corp.

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

  • 척수 자극 시장(2029년) : 새로운 기회를 제공하는 국가
  • 척수 자극 시장(2029년) : 새로운 기회를 제공하는 부문
  • 척수 자극 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

AJY 25.10.13

Spinal cord stimulation is a relatively recent technique designed to aid in the management of chronic pain when the underlying damage or cause cannot be remedied. This approach involves delivering electrical pulses directly into the spinal cord to regulate and control pain.

The primary types of spinal cord stimulation products are rechargeable and non-rechargeable. Rechargeable devices are those capable of being replenished with electricity. Rechargeable spinal cord stimulation is applied to address persistent neuropathic pain that persists after unsuccessful back surgery. Its applications extend to various conditions, including failed back surgery syndrome (FBSS), degenerative disc disease (DDD), complex regional pain syndrome (CRPS), arachnoiditis, among others. These products find use in different medical settings, including hospitals, ambulatory surgery centers, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The spinal cord stimulation market research report is one of a series of new reports from The Business Research Company that provides spinal cord stimulation market statistics, including spinal cord stimulation industry global market size, regional shares, competitors with a spinal cord stimulation market share, detailed spinal cord stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation industry. This spinal cord stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spinal cord stimulation market size has grown strongly in recent years. It will grow from $3.14 billion in 2024 to $3.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to aging population, increasing prevalence of chronic pain, rising awareness about spinal cord stimulation, and growing demand for non-invasive pain management techniques.

The spinal cord stimulation market size is expected to see strong growth in the next few years. It will grow to $4.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of innovative stimulation therapies, expanding indications for spinal cord stimulation, rising demand for minimally invasive procedures, increasing investment in research and development, reimbursement policies. Major trends in the forecast period include the integration of artificial intelligence in spinal cord stimulation devices, the emergence of non-paraesthesia-based stimulation, the focus on expanding market presence in emerging economies, the adoption of rechargeable stimulators, and emphasis on patient-centric approaches in product development.

The forecast of 8.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced pain management by inflating prices of implantable neurostimulators and rechargeable battery systems developed in Switzerland and Ireland, resulting in prolonged patient suffering and higher pain clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected rise in the prevalence of spinal cord injuries is anticipated to drive the growth of the spinal cord stimulation market in the future. Spinal cord injuries encompass any damage to the spinal cord or nerves within the spinal canal, often resulting from traumatic incidents or domestic accidents. The treatment for spinal cord injuries involves spinal cord stimulation, a process that delivers low-voltage electricity to the spinal cord to alleviate pain. As of May 2022, the National Library of Medicine reported that spinal cord injuries affected between 250,000 and 500,000 individuals globally each year. In the United States alone, approximately 17,000 new spinal cord injuries are reported annually, with an estimated 282,000 Americans considered survivors of spinal cord injuries. Consequently, the growing prevalence of spinal cord injuries is serving as a catalyst for the expansion of the spinal cord stimulation market.

The rising geriatric population is anticipated to drive the growth of the spinal cord stimulation market. Individuals aged 65 and older, referred to as the geriatric population, have unique healthcare and social needs linked to the aging process. As the geriatric demographic expands, there is a substantial opportunity for the spinal cord stimulation market to grow. With an increase in chronic pain and related health issues among this age group, the demand for spinal cord stimulation solutions is expected to rise, further contributing to market expansion. For example, in October 2022, the World Health Organization, a U.S.-based specialized health agency, reported that by 2030, 1 in 6 people worldwide will be 60 years or older, with this number projected to double to 2.1 billion by 2050. Therefore, the growing geriatric population is driving the growth of the spinal cord stimulation market.

Technological innovations are a prominent trend gaining traction in the spinal cord stimulation market, with major companies focusing on advanced solutions to maintain their market positions. In December 2022, Abbott Laboratories, a US-based medical device company, introduced the Eterna spinal cord stimulation system, the smallest implantable, rechargeable spinal cord stimulator for chronic pain management currently available. Utilizing Abbott's low-dose BurstDR stimulation, the Eterna SCS has demonstrated a 23% greater relief of pain compared to conventional waveform technology methods, providing a technologically advanced solution for chronic pain treatment.

Major players in the spinal cord stimulation market are concentrating on developing innovative products, such as the Spinal Cord Stimulation System, representing a significant advancement in therapy for spinal cord stimulation. The system involves the implantation of electrodes along the spinal cord to alleviate chronic pain. In March 2023, Nevro, a US-based medical device company specializing in chronic pain treatment, launched the Revolutionary HFX iQ Spinal Cord Stimulation System. Distinguished by its use of artificial intelligence, the system offers personalized pain relief through real-time adjustments based on extensive clinical data. Featuring the HFX algorithm and comprehensive pain management, this system not only represents a significant advancement in spinal cord stimulation therapy but also contributes to the market by offering innovative, data-backed, and AI-powered solutions for individuals with chronic pain.

In November 2023, Nevro, a US-based medical device company for chronic pain, completed the acquisition of VYRSA Technologies for an upfront payment of $40 million and an additional $35 million in milestone payments. This acquisition is notable in the spinal cord stimulation market, diversifying Nevro's product offering, expanding its portfolio and market reach, and addressing unmet medical needs in chronic pain treatment. VYRSA Technologies is a US-based medical technology company with a focus on sacroiliac joint fusion.

Major companies operating in the spinal cord stimulation market include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corp., LivaNova PLC, Globus Medical Inc., ZimVie Inc., Avanos Medical Inc. , Nevro Corp., Axonics Modulation Technologies Inc., SPR Therapeutics Inc., BlueWind Medical, Bioness Inc., Saluda Medical Pty. Ltd., Soterix Medical Inc., Synapse Biomedical Inc., NeuroMetrix Inc., NDI Medical LLC, Neuros Medical Inc., Cirtec Medical Corp., Mainstay Medical International plc, Gimer Medical

North America was the largest region in the spinal cord stimulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spinal cord stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal cord stimulation market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Cord Stimulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal cord stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal cord stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spinal cord stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Rechargeable; Non-rechargeable
  • 2) By Application: Failed Back Surgery Syndrome (FBSS); Degenerative Disc Disease (DDD); Complex Regional Pain Syndrome (CRPS); Arachnoiditis; Other Disease Indications
  • 3) By End User: Hospitals; Ambulatory Surgery Centers; Specialty Clinics
  • Subsegments:
  • 1) By Rechargeable: Implantable Pulse Generators (IPGs); Rechargeable Lead Systems
  • 2) By Non-Rechargeable: Non-Rechargeable Implantable Pulse Generators (IPGs); Non-Rechargeable Lead Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Stryker Corporation; Boston Scientific Corp.; LivaNova PLC; Globus Medical Inc.; ZimVie Inc.; Avanos Medical Inc. ; Nevro Corp.; Axonics Modulation Technologies Inc.; SPR Therapeutics Inc.; BlueWind Medical; Bioness Inc.; Saluda Medical Pty. Ltd.; Soterix Medical Inc.; Synapse Biomedical Inc.; NeuroMetrix Inc.; NDI Medical LLC; Neuros Medical Inc.; Cirtec Medical Corp.; Mainstay Medical International plc; Gimer Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spinal Cord Stimulation Market Characteristics

3. Spinal Cord Stimulation Market Trends And Strategies

4. Spinal Cord Stimulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Spinal Cord Stimulation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Spinal Cord Stimulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Spinal Cord Stimulation Market Growth Rate Analysis
  • 5.4. Global Spinal Cord Stimulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Spinal Cord Stimulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Spinal Cord Stimulation Total Addressable Market (TAM)

6. Spinal Cord Stimulation Market Segmentation

  • 6.1. Global Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rechargeable
  • Non-rechargeable
  • 6.2. Global Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Failed Back Surgery Syndrome (FBSS)
  • Degenerative Disc Disease (DDD)
  • Complex Regional Pain Syndrome (CRPS)
  • Arachnoiditis
  • Other Disease Indications
  • 6.3. Global Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • 6.4. Global Spinal Cord Stimulation Market, Sub-Segmentation Of Rechargeable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Pulse Generators (IPGs)
  • Rechargeable Lead Systems
  • 6.5. Global Spinal Cord Stimulation Market, Sub-Segmentation Of Non-Rechargeable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Rechargeable Implantable Pulse Generators (IPGs)
  • Non-Rechargeable Lead Systems

7. Spinal Cord Stimulation Market Regional And Country Analysis

  • 7.1. Global Spinal Cord Stimulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Spinal Cord Stimulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spinal Cord Stimulation Market

  • 8.1. Asia-Pacific Spinal Cord Stimulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spinal Cord Stimulation Market

  • 9.1. China Spinal Cord Stimulation Market Overview
  • 9.2. China Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spinal Cord Stimulation Market

  • 10.1. India Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spinal Cord Stimulation Market

  • 11.1. Japan Spinal Cord Stimulation Market Overview
  • 11.2. Japan Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spinal Cord Stimulation Market

  • 12.1. Australia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spinal Cord Stimulation Market

  • 13.1. Indonesia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spinal Cord Stimulation Market

  • 14.1. South Korea Spinal Cord Stimulation Market Overview
  • 14.2. South Korea Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spinal Cord Stimulation Market

  • 15.1. Western Europe Spinal Cord Stimulation Market Overview
  • 15.2. Western Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spinal Cord Stimulation Market

  • 16.1. UK Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spinal Cord Stimulation Market

  • 17.1. Germany Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spinal Cord Stimulation Market

  • 18.1. France Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spinal Cord Stimulation Market

  • 19.1. Italy Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spinal Cord Stimulation Market

  • 20.1. Spain Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spinal Cord Stimulation Market

  • 21.1. Eastern Europe Spinal Cord Stimulation Market Overview
  • 21.2. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spinal Cord Stimulation Market

  • 22.1. Russia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spinal Cord Stimulation Market

  • 23.1. North America Spinal Cord Stimulation Market Overview
  • 23.2. North America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spinal Cord Stimulation Market

  • 24.1. USA Spinal Cord Stimulation Market Overview
  • 24.2. USA Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spinal Cord Stimulation Market

  • 25.1. Canada Spinal Cord Stimulation Market Overview
  • 25.2. Canada Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spinal Cord Stimulation Market

  • 26.1. South America Spinal Cord Stimulation Market Overview
  • 26.2. South America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spinal Cord Stimulation Market

  • 27.1. Brazil Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spinal Cord Stimulation Market

  • 28.1. Middle East Spinal Cord Stimulation Market Overview
  • 28.2. Middle East Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spinal Cord Stimulation Market

  • 29.1. Africa Spinal Cord Stimulation Market Overview
  • 29.2. Africa Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spinal Cord Stimulation Market Competitive Landscape And Company Profiles

  • 30.1. Spinal Cord Stimulation Market Competitive Landscape
  • 30.2. Spinal Cord Stimulation Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Spinal Cord Stimulation Market Other Major And Innovative Companies

  • 31.1. Globus Medical Inc.
  • 31.2. ZimVie Inc.
  • 31.3. Avanos Medical Inc.
  • 31.4. Nevro Corp.
  • 31.5. Axonics Modulation Technologies Inc.
  • 31.6. SPR Therapeutics Inc.
  • 31.7. BlueWind Medical
  • 31.8. Bioness Inc.
  • 31.9. Saluda Medical Pty. Ltd.
  • 31.10. Soterix Medical Inc.
  • 31.11. Synapse Biomedical Inc.
  • 31.12. NeuroMetrix Inc.
  • 31.13. NDI Medical LLC
  • 31.14. Neuros Medical Inc.
  • 31.15. Cirtec Medical Corp.

32. Global Spinal Cord Stimulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spinal Cord Stimulation Market

34. Recent Developments In The Spinal Cord Stimulation Market

35. Spinal Cord Stimulation Market High Potential Countries, Segments and Strategies

  • 35.1 Spinal Cord Stimulation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Spinal Cord Stimulation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Spinal Cord Stimulation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제